These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 30060855)

  • 21. Comparison of copper intrauterine device with levonorgestrel-bearing intrauterine system for post-abortion contraception.
    Bilgehan F; Dilbaz B; Karadag B; Deveci CD
    J Obstet Gynaecol Res; 2015 Sep; 41(9):1426-32. PubMed ID: 26180028
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anticipated pain as a predictor of discomfort with intrauterine device placement.
    Dina B; Peipert LJ; Zhao Q; Peipert JF
    Am J Obstet Gynecol; 2018 Feb; 218(2):236.e1-236.e9. PubMed ID: 29079143
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Levonorgestrel-releasing IUD as a method of contraception with therapeutic properties.
    Luukkainen T; Toivonen J
    Contraception; 1995 Nov; 52(5):269-76. PubMed ID: 8585882
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Predictors of Discontinuation of Long-Acting Reversible Contraception Before 30 Months of Use by Adolescents and Young Women.
    Cohen R; Sheeder J; Teal SB
    J Adolesc Health; 2019 Aug; 65(2):295-302. PubMed ID: 31196778
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Factors Associated With Contraceptive Method Choice and Initiation in Adolescents and Young Women.
    Cohen R; Sheeder J; Kane M; Teal SB
    J Adolesc Health; 2017 Oct; 61(4):454-460. PubMed ID: 28712596
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A multicenter randomized clinical trial of one-rod etonogestrel and two-rod levonorgestrel contraceptive implants with nonrandomized copper-IUD controls: methodology and insertion data.
    Meirik O; Brache V; Orawan K; Habib NA; Schmidt J; Ortayli N; Culwell K; Jackson E; Ali M;
    Contraception; 2013 Jan; 87(1):113-20. PubMed ID: 23063337
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cochrane systematic reviews of IUD trials: lessons learned.
    Grimes DA; Lopez LM; Manion C; Schulz KF
    Contraception; 2007 Jun; 75(6 Suppl):S55-9. PubMed ID: 17531618
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anticipated Pain During Intrauterine Device Insertion.
    Hunter TA; Sonalkar S; Schreiber CA; Perriera LK; Sammel MD; Akers AY
    J Pediatr Adolesc Gynecol; 2020 Feb; 33(1):27-32. PubMed ID: 31563628
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Five years private practice experience of nulliparous women using copper IUD's.
    Smith RP; Goresky DM; Etchell DM
    Contraception; 1980 Apr; 21(4):335-42. PubMed ID: 7389354
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term utilization and continuation of intrauterine devices.
    Diedrich JT; Madden T; Zhao Q; Peipert JF
    Am J Obstet Gynecol; 2015 Dec; 213(6):822.e1-6. PubMed ID: 26409157
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Preference for and efficacy of oral levonorgestrel for emergency contraception with concomitant placement of a levonorgestrel IUD: a prospective cohort study.
    Turok DK; Sanders JN; Thompson IS; Royer PA; Eggebroten J; Gawron LM
    Contraception; 2016 Jun; 93(6):526-32. PubMed ID: 26944863
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Postpartum IUDS: keys for success.
    O'Hanley K; Huber DH
    Contraception; 1992 Apr; 45(4):351-61. PubMed ID: 1516367
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Six-month and 1-year continuation rates following postpartum insertion of implants and intrauterine devices.
    Woo I; Seifert S; Hendricks D; Jamshidi RM; Burke AE; Fox MC
    Contraception; 2015 Dec; 92(6):532-5. PubMed ID: 26408376
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Choice of the levonorgestrel intrauterine device, etonogestrel implant or depot medroxyprogesterone acetate for contraception after aspiration abortion.
    Steinauer JE; Upadhyay UD; Sokoloff A; Harper CC; Diedrich JT; Drey EA
    Contraception; 2015 Dec; 92(6):553-9. PubMed ID: 26093190
    [TBL] [Abstract][Full Text] [Related]  

  • 35. New developments in intrauterine devices.
    Farr G
    Netw Res Triangle Park N C; 1991 Sep; 12(2):9. PubMed ID: 12284281
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Initiation and continuation of long-acting reversible contraception in the United States military healthcare system.
    Chiles DP; Roberts TA; Klein DA
    Am J Obstet Gynecol; 2016 Sep; 215(3):328.e1-9. PubMed ID: 27005514
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Post-marketing surveillance of Norplant contraceptive implants: I. Contraceptive efficacy and reproductive health.
    International Collaborative Post-Marketing Surveillance of Norplant
    Contraception; 2001 Apr; 63(4):167-86. PubMed ID: 11376646
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interactions between intrauterine contraceptive device use and breast-feeding status at time of intrauterine contraceptive device insertion: analysis of TCu-380A acceptors in developing countries.
    Farr G; Rivera R
    Am J Obstet Gynecol; 1992 Jul; 167(1):144-51. PubMed ID: 1442918
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Health care provider attitudes and practices related to intrauterine devices for nulliparous women.
    Tyler CP; Whiteman MK; Zapata LB; Curtis KM; Hillis SD; Marchbanks PA
    Obstet Gynecol; 2012 Apr; 119(4):762-71. PubMed ID: 22433340
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Satisfaction With the Intrauterine Device Insertion Procedure Among Adolescent and Young Adult Women.
    Akers AY; Harding J; Perriera LK; Schreiber C; Garcia-Espana JF; Sonalkar S
    Obstet Gynecol; 2018 Jun; 131(6):1130-1136. PubMed ID: 29742656
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.